Abstract: . . .  cerebral ischemia of presumed arterial origin . Ann Neurol 1997, 42 :857865. 12. Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and popula- tions . Lancet 1999, 354 :14571463. 13. Algra A, van Gijn J, Kappelle LJ, Koudstaal PJ, Stam J, Vermeulen M: Creatief cijferen met clopidogrel; overschatting van het preventief effect door de fabrikant . Ned Tijdschr Geneeskd 1999, 143 :2479. 14. Algra A, van Gijn J: Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia . J Neurol Neurosurg Psychiatry 1996, 60 :197199. 15. Algra A, van Gijn J: Cumulative meta-analysis of aspirin efficacy . . .
. . .  commentary review reports primary research Commentary Is clopidogrel superior to aspirin in secondary prevention of vascular disease ? Ale Algra* and Jan van Gijn* *University Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlands and Julius Center for General Practice and Patient Oriented Research, University Medical Center Utrecht, Utrecht, . . .
. . .  cijferen met clopidogrel; overschatting van het preventief effect door de fabrikant . Ned Tijdschr Geneeskd 1999, 143 :2479. 14. Algra A, van Gijn J: Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia . J Neurol Neurosurg Psychiatry 1996, 60 :197199. 15. Algra A, van Gijn J: Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin [letter] . J Neurol Neuro- surg Psychiatry 1999, 66 :255. Authors affiliations: Ale Algra (University Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlands and Julius Center for General Practice and Patient Oriented Research, University Medical . . .
. . .  comes are most relevant to stroke patients? Neurology 2000, 54 : 10221028. 11. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin . Ann Neurol 1997, 42 :857865. 12. Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and popula- tions . Lancet 1999, 354 :14571463. 13. Algra A, van Gijn J, Kappelle LJ, Koudstaal PJ, Stam J, Vermeulen M: Creatief cijferen met clopidogrel; overschatting van het preventief effect door de fabrikant . Ned Tijdschr Geneeskd 1999, 143 :2479. 14. . . .
--3000,4,375,3069,16184